This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Almirall, S.a.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Francisco Javier Bernal Anchuela: Innovator in Pharmaceutical Chemistry
Introduction
Francisco Javier Bernal Anchuela is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific biological pathways.
Latest Patents
Bernal Anchuela holds two patents that focus on pyrrolotriazinone derivatives as inhibitors of Phosphoinositide 3-Kinases (PI3Ks). The first patent discloses new pyrrolotriazinone derivatives with a specific chemical structure, along with the processes for their preparation, pharmaceutical compositions that include these compounds, and their therapeutic applications. The second patent similarly details new pyrrolotriazinone derivatives and their use as PI3K inhibitors, emphasizing their potential in therapeutic settings.
Career Highlights
He is currently associated with Almirall, S.A., a prominent pharmaceutical company. His work at Almirall has allowed him to focus on innovative drug development, contributing to advancements in therapeutic options for various diseases.
Collaborations
Some of his notable coworkers include Marta Carrascal Riera and Juan Francisco Caturla Javaloyes. Their collaborative efforts have further enhanced the research and development initiatives within their team.
Conclusion
Francisco Javier Bernal Anchuela's work exemplifies the impact of innovative research in pharmaceutical chemistry. His patents on pyrrolotriazinone derivatives highlight his commitment to advancing therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile